A new HLA-B allele, HLA-B*07:422.

Alleles Exons / genetics HLA-B7 Antigen High-Throughput Nucleotide Sequencing Humans
HLA-B*07:422 new allele next-generation sequencing based typing

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
02 2022
Historique:
revised: 29 10 2021
received: 15 10 2021
accepted: 29 10 2021
pubmed: 4 11 2021
medline: 29 4 2022
entrez: 3 11 2021
Statut: ppublish

Résumé

The novel allele HLA-B*07:422 differs from HLA-B*07:02:01:01 by one nucleotide substitution in exon 4.

Identifiants

DOI: 10.1111/tan.14478 PMID: 34729959
pubmed: 34729959
doi: 10.1111/tan.14478
doi:

Substances chimiques

HLA-B*07 antigen 0
HLA-B7 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-119

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P. Marsh SGE: IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Mariarosa Battarra (M)

Transplant Immunogenetics Laboratory, IRCCS, Bambin Gesù Pediatric Hospital, Rome, Italy.
ORCID: 0000-0002-7506-2383

Andrea Di Luzio (A)

Transplant Immunogenetics Laboratory, IRCCS, Bambin Gesù Pediatric Hospital, Rome, Italy.

Antonio Giuseppe Bianculli (AG)

Transplant Immunogenetics Laboratory, IRCCS, Bambin Gesù Pediatric Hospital, Rome, Italy.

Rita Maria Pinto (RM)

Department of Oncohematology and cell and Gene Therapy, IRCCS, Bambin Gesù Pediatric Hospital, Rome, Italy.

Marco Andreani (M)

Transplant Immunogenetics Laboratory, IRCCS, Bambin Gesù Pediatric Hospital, Rome, Italy.
ORCID: 0000-0003-3451-3624

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › A new HLA-B allele, HLA-B*07:422.
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Exons › A new HLA-B allele, HLA-B*07:422.
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-B › Antigène HLA-B7 › A new HLA-B allele, HLA-B*07:422.
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › A new HLA-B allele, HLA-B*07:422.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A new HLA-B allele, HLA-B*07:422.